Table 3 Percentage of patients according to the number of prescribed anti-hypertensive compounds and to the patients’ final status (controlled, non- controlled, without BP recording) at baseline and at study’s end
Baseline | Total | Controlled | Non controlled | Without recording |
|---|---|---|---|---|
0 | 17.3% | 9.8% | 15.6% | 30.0% |
1 | 56.1% | 61.8% | 53.9% | 48.2% |
2 | 20.7% | 21.9% | 23.1% | 17.3% |
3 | 5.0% | 5.4% | 5.8% | 3.9% |
4 | 0.9% | 0.9% | 1.2% | 0.5% |
>4 | 0.2% | 0.2% | 0.4% | 0.1% |
Study’s end | Total | Controlled | Non controlled | Without recording |
0 | 17.2% | 10.0% | 13.8% | 40.6% |
1 | 55.6% | 61.1% | 55.6% | 39.4% |
2 | 21.0% | 22.5% | 22.4% | 15.4% |
3 | 5.1% | 5.1% | 6.5% | 4.1% |
4 | 1.0% | 1.1% | 1.4% | 0.4% |
>4 | 0.1% | 0.1% | 0.2% | 0.1% |